(Total Views: 65)
Posted On: 12/10/2024 11:48:41 AM
Post# of 99246

$DYAI Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology https://finance.yahoo.com/news/dyadic-receive...00271.html

